Skip to content

The PC-LIGHT Study

Systematic Light Exposure to Prevent Fatigue in Prostate Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03419585
Enrollment
75
Registered
2018-02-05
Start date
2018-12-12
Completion date
2023-12-31
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Fatigue, Prostate Cancer, Quality of Life, Sleep

Brief summary

Fatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining preventative approaches has produced limited clinical benefit. The proposed study will provide information about systematic light exposure for the prevention of fatigue in prostate cancer patients undergoing radiation therapy and will investigate how it works. This study would facilitate the development of this potential preventative treatment, giving health care providers and cancer survivors a much-needed tool to help with cancer-related fatigue.

Interventions

30 minutes of intervention systematic light exposure daily

30 minutes of comparison systematic light exposure daily

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

Participants will be randomized to one of two arms: an intervention light group or a comparison light group. Both the participant and the investigator will be blind to the light assignment.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have been diagnosed with clinical localized prostate cancer, * Are about to begin external beam radiation therapy (RT) for prostate cancer, * Are 18 years of age or older, * Are able to speak or read English, * Have internet access.

Exclusion criteria

* History of light therapy use (e.g. systematic light exposure), * Active infection * History of chronic fatigue disorders * Confounding underlying medical illnesses such as significant pre-existing anemia (Hb\<10 gm/dl) * Diagnosed or suspected psychiatric or medical condition that might contribute to fatigue (other than those caused by the cancer or its treatment) * Hypothyroidism or documented history of hypothyroidism on thyroid replacement hormone within \<3 months of initiating RT * History of bipolar disorder or mania * History of seasonal affective disorder * Diagnosed sleep apnea, restless legs, or other sleep disorders (not including insomnia) known to affect fatigue * Use of photosensitizing medication * Plans to travel across more than 2 time zones during the study * Shift worker * Adults unable to consent, individuals who are not yet adults, pregnant women, and prisoners will be excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
Fatigue FACIT-Fatigue scoresBaselineFACIT-Fatigue scores
FatigueChange from Baseline to the 4th week of the interventionFACIT-Fatigue scores

Secondary

MeasureTime frameDescription
Circadian activity rhythmsBaselineActigraphy
Cognitive FunctioningBaselinePsychometric Analysis of the Patient Assessment of Own Functioning Inventory (PAOFI)
Sleep qualityBaselinePittsburgh Sleep Quality Index (PSQI)
Depressed moodBaselineCenter for Epidemiologic Studies Depression Scale (CESD). Score range is 0 to 60, where higher scores represent more symptomatology present.
Sexual and urinary functioningBaseline3 items from the Sexual Adjustment Questionnaire & 3 items from American Urological Association (AUA) symptom index
Cognitive functioningBaselineNeuropsychological tests
Health-related quality of lifeBaselineFunctional Assessment of Cancer Therapy - Prostate (FACT-P). From Radiation Therapy Oncology Group: The FACT-P is a multidimensional, self-report QoL instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being.with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being.

Other

MeasureTime frameDescription
ChronotypeBaselineMorningness-eveningness questionnaire. From the item itself: Scores can range from 4-25. Scores of 7 and below indicate evening types. Scores of 22 and above indicate morning types. Scores between 8-21 indicate intermediate types.
BMIBaselineBMI table
Physical healthBaselineGoldin Leisure Time Exercise Questionnaire. From the measure itself: For the first question, weekly frequencies of strenuous, moderate, and light activities are multiplied by nine, five, and three, respectively. Total weekly leisure activity is calculated in arbitrary units by summing the products of the separate components, as shown in the following formula: Weekly leisure activity score = (9 × Strenuous) + (5 × Moderate) + (3 × Light) The second question is used to calculate the frequency of weekly leisure-time activities pursued long enough to work up a sweat (see questionnaire).
Usage of light boxThroughout intervention period (8 weeks)integrated meter measurement and Litebook log. Length of time light box has been used.
Credibility/ExpectancyBaselineCredibility/Expectancy questionnaire. There are two scales used during the questionnaire - (1-9, and 0-100%). A composite score can be calculated for each factor (expectancy and credibility).
Treatment satisfactionDuring the 8th week of the interventionFunctional Assessment of Cancer Therapy - Treatment Satisfaction - General (FACT-TS-G)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026